Mangoceuticals (NASDAQ:MGRX) Posts Quarterly Earnings Results

Mangoceuticals (NASDAQ:MGRX) issued its quarterly earnings results on Thursday. The company reported ($1.01) earnings per share (EPS) for the quarter, Zacks reports. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%. The firm had revenue of $0.11 million for the quarter.

Mangoceuticals Trading Up 2.5 %

NASDAQ:MGRX opened at $4.46 on Friday. Mangoceuticals has a 1-year low of $2.07 and a 1-year high of $16.80. The business’s 50-day moving average price is $3.82 and its two-hundred day moving average price is $14.60. The firm has a market capitalization of $11.09 million, a price-to-earnings ratio of -0.77 and a beta of 1.51.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.